Literature DB >> 11346333

A unique microvascular phenotype shared by juvenile hemangiomas and human placenta.

P E North1, M Waner, A Mizeracki, R E Mrak, R Nicholas, J Kincannon, J Y Suen, M C Mihm.   

Abstract

BACKGROUND: Juvenile hemangiomas are common, benign tumors, distinctive for their perinatal presentation, rapid growth during the first year of life, and subsequent involution. We recently reported that endothelia of hemangiomas highly express GLUT1, a glucose transporter normally restricted to endothelia with blood-tissue barrier function, as in brain and placenta.
OBJECTIVE: To investigate possible further similarities between hemangioma and placental vessels.
DESIGN: In a retrospective study of a variety of vascular tumors and anomalies, we assessed lesional immunoreactivities for the placenta-associated vascular antigens FcgammaRII, Lewis Y antigen (LeY), merosin, and GLUT1.
SETTING: A university-affiliated pediatric hospital. MAIN OUTCOME MEASURE: Immunoreactivities scored for each antigen were summarized according to lesional type, compared with those of normal skin, brain, and placenta, and correlated with patient age, sex, and lesional location.
RESULTS: All of 66 hemangiomas (patients aged 22 days to 7 years) showed intense immunoreactivity for FcgammaRII, merosin, LeY, and GLUT1. No immunoreactivities for these markers were seen in any of 26 vascular malformations, 4 granulation tissue specimens, 13 pyogenic granulomas, or in the tumor vasculature of 6 malignant tumors of nonvascular origin. Microvascular immunoreactivity for all 4 markers was observed in placental chorionic villi, but was absent in microvessels of normal skin and subcutis. Brain microvessels expressed only GLUT1 and merosin.
CONCLUSIONS: A distinct constellation of tissue-specific markers is uniquely coexpressed by hemangiomas and placental microvessels. These findings imply a unique relationship between hemangioma and the placenta and suggest new hypotheses concerning the origin of these tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346333

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  60 in total

Review 1.  Pathogenesis of hemangioma.

Authors:  D A Marchuk
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Retinal neovascular markers in retinopathy of prematurity: aetiological implications.

Authors:  P E North; D C Anthony; T L Young; M Waner; H H Brown; M C Brodsky
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

Review 3.  Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I).

Authors:  Sherief R Janmohamed; Gerard C Madern; Peter C J de Laat; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2014-08-26       Impact factor: 3.183

Review 4.  Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.

Authors:  Chelsey J Forbess Smith; Sheila Fallon Friedlander; Monica Guma; Arthur Kavanaugh; Christina D Chambers
Journal:  Birth Defects Res       Date:  2017-04-12       Impact factor: 2.344

5.  Myeloid cells in infantile hemangioma.

Authors:  Matthew R Ritter; John Reinisch; Sheila Fallon Friedlander; Martin Friedlander
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

6.  Infantile hemangiomas: A review.

Authors:  Alison B Callahan; Michael K Yoon
Journal:  Saudi J Ophthalmol       Date:  2012-05-23

7.  Prenatal Risk Factors for PHACE Syndrome: A Study Using the PHACE Syndrome International Clinical Registry and Genetic Repository.

Authors:  Joy Wan; Jack Steiner; Eulalia Baselga; Francine Blei; Maria Cordisco; Maria C Garzon; Deborah S Goddard; Anita Haggstrom; Alfons Krol; Ilona J Frieden; Denise Metry; Kimberly D Morel; Judith M A Verhagen; Orli Wargon; Beth A Drolet; Dawn H Siegel
Journal:  J Pediatr       Date:  2017-09-01       Impact factor: 4.406

8.  Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma.

Authors:  Graham M Strub; Andrew L Kirsh; Mark E Whipple; Winston P Kuo; Rachel B Keller; Raj P Kapur; Mark W Majesky; Jonathan A Perkins
Journal:  JCI Insight       Date:  2016-09-08

9.  Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.

Authors:  Ezinne Francess Mong; Kemal Marc Akat; John Canfield; John Lockhart; Jeffrey VanWye; Andrew Matar; John C M Tsibris; June K Wu; Thomas Tuschl; Hana Totary-Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-03       Impact factor: 8.311

10.  Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas.

Authors:  Guillaume Gorincour; Victor Kokta; Francoise Rypens; Laurent Garel; Julie Powell; Josée Dubois
Journal:  Pediatr Radiol       Date:  2005-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.